The effect of entecavir treatment on HBV-specific immunity in patient with chronic hepatitis B and its relationship to HBeAg sero-conversion / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology
;
(6): 122-123, 2008.
Article
in Chinese
| WPRIM
| ID: wpr-254124
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the effect of Entecavir treatment on HBV-specific immunity in patient with chronic hepatitis B and its relationship to HBeAg sero-conversion.</p><p><b>METHODS</b>Serum aminotransferase (ALT), HBV DNA and HBeAg were monitored before the after entecavir treatment. At the same time point, HBV-specific T cell proliferation was determined by [3H] T-dR incorporation assay, while HBV-specific IFN-alpha secretion was measured by ELISA.</p><p><b>RESULTS</b>The level of HBV DNA and ALT was significantly decreased after entecavir treatment. Same is the titer of HBeAg. In addition, HBeAg sero-conversion was observed in some of them, in whom the HBV-specific T cell proliferation and IFN-alpha production were significantly increased.</p><p><b>CONCLUSION</b>Entecavir treatment resulted in increased HBV-specific immunity along with the inhibition of HBV replication.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Time Factors
/
Virology
/
Blood
/
DNA, Viral
/
T-Lymphocytes
/
Hepatitis B virus
/
Treatment Outcome
/
Interferon-alpha
/
Hepatitis B, Chronic
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Chinese Journal of Experimental and Clinical Virology
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS